Allarity to present stenoparib Phase 2 poster at ESMO congress

June 18, 2026 8:00 AM

Allarity Therapeutics, Inc. (NASDAQ: ALLR) announced it presented a Trial-in-Progress poster at the ESMO Gynaecological Cancers Congress 2026, held June ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found